Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyposaline LUSO Mineral Water Drives Murine Macrophage Polarization Towards an Anti-Inflammatory M2 Phenotype.

Food science & nutrition·2026
Same author

Essential Oils: Chemistry and Mechanisms of Anticonvulsant Action.

International journal of molecular sciences·2026
Same author

Phenolic Profile and Antioxidant Activity of Chocolates Supplemented with Bioactive Ingredients.

Foods (Basel, Switzerland)·2026
Same author

Multifunctional Activity of <i>Lippia gracilis</i> Schauer Essential Oil Against Skin Infections.

Plants (Basel, Switzerland)·2026
Same author

In Vitro Antifungal and Wound-Healing Potential of <i>Ferulago cassia</i> and <i>Ferulago silaifolia</i> Essential Oils in Skin Candidiasis.

Antibiotics (Basel, Switzerland)·2026
Same author

Anti-Inflammatory Evaluation of Pyrazino[2,1-<i>b</i>]quinazoline-3,6-dione Derivatives Inspired by Fiscalin B.

Pharmaceuticals (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 28, 2026

A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC)
10:09

A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC)

Published on: March 15, 2017

Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents.

Sandrine Ressurreição1,2,3, Sónia A Pinho1,4, Maria Teresa Cruz1,4

  • 1University of Coimbra, Faculty of Pharmacy, 3000-548 Coimbra, Portugal.

Pharmaceuticals (Basel, Switzerland)
|May 27, 2026
PubMed
Summary
This summary is machine-generated.

Glucosinolates from Brassicaceae plants yield compounds with anti-inflammatory and antioxidant effects by modulating key signaling pathways. Further research is needed to explore the therapeutic potential of these diverse compounds.

Keywords:
MMPsNF-κBNRF2anti-inflammatory activityglucosinolate derivates

More Related Videos

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

Related Experiment Videos

Last Updated: May 28, 2026

A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC)
10:09

A Straightforward Method for Glucosinolate Extraction and Analysis with High-pressure Liquid Chromatography (HPLC)

Published on: March 15, 2017

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions
08:56

Synthesis of a Borylated Ibuprofen Derivative Through Suzuki Cross-Coupling and Alkene Boracarboxylation Reactions

Published on: November 30, 2022

Area of Science:

  • Plant biochemistry and pharmacology
  • Natural product chemistry
  • Immunology and inflammation research

Background:

  • Glucosinolates are sulfur-containing plant metabolites found in Brassicaceae species.
  • Enzymatic hydrolysis of glucosinolates produces bioactive compounds with anti-inflammatory properties.
  • These derivatives modulate nuclear factor-kappa B (NF-κB) and nuclear factor erythroid 2-related factor 2 (NRF2) signaling pathways.

Purpose of the Study:

  • To systematically review plant species containing glucosinolates and their anti-inflammatory potential.
  • To highlight the anti-inflammatory and antioxidant activities of glucosinolate derivatives.
  • To identify knowledge gaps regarding the functional investigation of glucosinolates.

Main Methods:

  • Systematic literature survey of plant species reported as glucosinolate sources.
  • Emphasis on studies evaluating plant extracts and fractions for anti-inflammatory potential.
  • Focus on in vitro and in vivo experimental models of inflammation and oxidative stress.

Main Results:

  • Glucosinolate derivatives inhibit NF-κB, reduce pro-inflammatory cytokines (TNF-α, IL-6, IL-1β), and suppress iNOS and COX-2.
  • These compounds activate NRF2-dependent antioxidant defenses (HO-1, NQO1) and regulate matrix metalloproteinases (MMPs).
  • Evidence supports the attenuation of inflammation and oxidative stress by glucosinolates in vitro and in vivo.

Conclusions:

  • A significant gap exists as only a small fraction of identified glucosinolates have been functionally investigated for their therapeutic potential.
  • Glucosinolate derivatives demonstrate considerable promise for developing novel anti-inflammatory and antioxidant agents.
  • Further research is crucial to fully explore the therapeutic applications of the diverse range of glucosinolates.